
### [NCIT:C3862](http://purl.obolibrary.org/obo/NCIT_C3862)
**Label:** Male Breast Carcinoma

**Subclasses:** [NCIT:C3862](http://purl.obolibrary.org/obo/NCIT_C3862) (Male Breast Carcinoma), [NCIT:C36106](http://purl.obolibrary.org/obo/NCIT_C36106) (Hereditary Male Breast Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C3862](http://purl.obolibrary.org/obo/NCIT_C3862) (Male Breast Carcinoma) 70.00%
- Thing 50.97%
- [NCIT:C6825](http://purl.obolibrary.org/obo/NCIT_C6825) (Numerical Chromosomal Abnormality) 37.35%
- [NCIT:C2950](http://purl.obolibrary.org/obo/NCIT_C2950) (Cytogenetic Abnormality) 35.03%
- [NCIT:C3910](http://purl.obolibrary.org/obo/NCIT_C3910) (Molecular Abnormality) 33.87%
- [NCIT:C36438](http://purl.obolibrary.org/obo/NCIT_C36438) (Chromosomal Gain) 29.45%
- [NCIT:C4872](http://purl.obolibrary.org/obo/NCIT_C4872) (Breast Carcinoma) 26.57%
- [NCIT:C9335](http://purl.obolibrary.org/obo/NCIT_C9335) (Malignant Breast Neoplasm) 25.95%
- [NCIT:C2910](http://purl.obolibrary.org/obo/NCIT_C2910) (Breast Neoplasm) 25.04%
- [NCIT:C26709](http://purl.obolibrary.org/obo/NCIT_C26709) (Breast Disorder) 24.96%
- [NCIT:C3263](http://purl.obolibrary.org/obo/NCIT_C3263) (Neoplasm by Site) 20.92%
- [NCIT:C27551](http://purl.obolibrary.org/obo/NCIT_C27551) (Disorder by Site) 20.90%
- [NCIT:C3262](http://purl.obolibrary.org/obo/NCIT_C3262) (Neoplasm) 20.89%
- [NCIT:C2991](http://purl.obolibrary.org/obo/NCIT_C2991) (Disease or Disorder) 20.87%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 20.87%


